Helicobacter pylori: Pathogenic Mechanisms

  • Conference paper
The Stomach

Abstract

H. pylori is a bacterium which colonizes the gastric mucosa. In 1896, Salomon described spiral organisms in stomachs of man and animals [1]. It was not until 1983, when Warren and Marshall first reported the isolation of a spiral bacterium from gastric biopsies of patients with gastritis [2, 3], that the dramatic expansion of information on H. pylori (Hp) began. Its worldwide distribution and high prevalence make it one of the commonest infections in mankind [4, 5]. Hp infection is associated with chronic type B gastritis, duodenal and gastric ulcer, and gastric carcinoma [6, 7] (Tables 1 and 2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Salomon H (1896) Ueber das Spirillum des Saugetiermagens und sein Verhalten zu den Belegzellen. Zentralbl Bakt (Naturwiss) 19: 433–443

    Google Scholar 

  2. Warren JR, Marshall B (1983) Unidentified cured bacilli on gastric epithelium in active chronic gastritis. Lancet i: 1273

    Google Scholar 

  3. Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet ii: 1273–1275

    Google Scholar 

  4. Goodwin CS, Armstrong JA, Marshall BJ (1986) Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathol 39: 353–365

    Article  PubMed  CAS  Google Scholar 

  5. Graham DY, Klein PD, Opekun AR, Boutton TW (1988) Effect of age on the frequency of active Campylobacter pyloridis infection diagnosed by the [13C] urea breath test in normal subjects and patients with peptic ulcer disease. J Infect Dis 157: 7777–7780

    Article  Google Scholar 

  6. Blaser MJ (1990) H. pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161: 626–633

    Article  PubMed  CAS  Google Scholar 

  7. Tytgat GNJ, Rauws EAJ, De Koster E (1988) Campylobacter pylori. Scand J Gastroenterol 155 (suppl): 68–81.

    Article  CAS  Google Scholar 

  8. Morris A, Nicholson G (1989) Experimental and accidental C. pylori infection of humans. In: Blaser MJ (ed) Campylobacter pylori in gastritis and peptic ulcer disease. Igaku-Shoin, New York, pp 61–72

    Google Scholar 

  9. Sipponen P, Kosunen TU, Valle J, Riihela, Seppala K (1992) H. pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 45: 319–323

    Article  PubMed  CAS  Google Scholar 

  10. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ (1991) H. pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325: 1132–1136

    Article  PubMed  CAS  Google Scholar 

  11. Talley NJ, Zinsmeister AR, DiMagno EP, Weaver A, Carpenter HA, Perez-Perez GI, Blaser MJ (1991) Gastric adenocarcinoma and H. pylori infection. J Natl Cancer Inst 83: 1734–1739

    Article  PubMed  CAS  Google Scholar 

  12. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley (1991) H. pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127 - 1131

    Article  PubMed  CAS  Google Scholar 

  13. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302–1305

    Article  PubMed  CAS  Google Scholar 

  14. Slomiany BL, Bilski J, Sarosiek J et al. (1987) Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 144: 307–314

    Article  PubMed  CAS  Google Scholar 

  15. Slomiany BL, Nishikawa H, Piotrowski J et al. (1989) Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion 43: 33–40

    Article  PubMed  CAS  Google Scholar 

  16. Yuonan F, Pearson J, Allen A et al. (1982) Changes in the structure of the mucus gel on the mucosal surface of the stomach in association with peptic ulcer. Gastroenterology 82: 817–831

    Google Scholar 

  17. Slomiany BL, Slomiany A (1991) Role of mucus in gastric mucosal protection. J Physiol Pharmacol 42: 149–163

    Google Scholar 

  18. Slomiany BL, Kasinathan C, Slomiany A (1989) Effect of colloidal bismuth subcitrate on the lipolytic activity of Campylobacter pylori. Gastroenterol 84: 1273–1277

    CAS  Google Scholar 

  19. Sidebotham RL, Baron JH (1990) Hypothesis: H. pylori, urease, mucus, and gastric ulcer. Lancet 335: 193–195

    Article  PubMed  CAS  Google Scholar 

  20. Morris A, Maher K, Thomsen L, Miller M, Nicholson G, Tasman-Jones C (1988) Distribution of Campylobacter pylori in the human stomach obtained at postmortem. Scand J Gastroenterol 23: 257–264

    Article  PubMed  CAS  Google Scholar 

  21. Hazel I SL, Hennessy WB, Borody TJ, Carrick J, Ralston M, Brady L, Lee A (1987) Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol 82: 297–301

    Google Scholar 

  22. Back GE, Gourley WK, Lee WK et al. (1986) Relation of Campylobacter pyloridis to gastritis and peptic ulcer. J Infect Dis 153: 664–669

    Article  Google Scholar 

  23. Price AB, Levi J, Dolby JM et al. (1985) Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut 26: 1183–1188

    Article  PubMed  CAS  Google Scholar 

  24. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y (1991) A topographical relationship between H. pylori and gastritis: Quantitative assessment of H. pylori in the gastric mucosa. Amer J Gastroenterol 86: 285–291

    CAS  Google Scholar 

  25. Karttunen T, Niemela S, Lehtola J et. al (1987) Campylobacter-like organisms and gastritis: Histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol 22: 478–486

    Article  PubMed  CAS  Google Scholar 

  26. Queiroz DMM, Barbosa A J A, Nendes EN et al. (1988) Distribution of Campylobacter pylori and gastritis in the stomach of patients with and without duodenal ulcer. Am J Gastroenterol 83: 1368–1370

    PubMed  CAS  Google Scholar 

  27. Bayerdorffer E, Oertel H, Lehn N et al. (1989) Topographical association between active gastritis and Campylobacter pylori colonization. J Clin Pathol 42: 834–839

    Article  PubMed  CAS  Google Scholar 

  28. Stolte M, Eidt S. Ohnsmann A (1990) Differences in H. pylori-associated gastritis in the antrum and body of the stomach. Z. Gastroenterol 28: 229–233

    PubMed  CAS  Google Scholar 

  29. Steininger H, Schneider U, Bartz K, Simmler B (1989) Campylobacter pylori und Gastritis — Besiedelungsdichte und Grad der Entzündung. Semiquantitative und morphometrische Untersuchung. Leber Magen Darm 19: 70–78

    PubMed  CAS  Google Scholar 

  30. Collins JSA, Sloan JM, Hamilton PW, Watt PCH, Love AHG (1989) Investigation of the relationship between gastric antral inflammation and Campylobacter pylori using graphic tablet planimetry. J Pathol 158: 281–285

    Article  Google Scholar 

  31. Goodwin CS, Armstrong JA, Marshall BK (1986) Campylobacter pyloridis gastritis and peptic ulcerations. J Clin Pathol 39: 353–365

    Article  PubMed  CAS  Google Scholar 

  32. Siurala M, Varis K, Wiljasalo M (1966) Studies of patients with atrophic gastritis: a 10–15 year follow up. Scand J Gastroenterol 1: 40–48

    PubMed  CAS  Google Scholar 

  33. Siurala M, Isokoski M, Varis K, Kekki M (1968) Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol 3: 211–223

    Article  PubMed  CAS  Google Scholar 

  34. Dooley CP, Cohen H, Fitzgibbons PL, Mauer M, Appleman MD, Perez-Perez GI, Blaser MJ (1989) Prevalence of H. pylori infection and histologic gastritis in asymptomatic ons. N Engl J Med 321: 1562–1566

    Article  PubMed  CAS  Google Scholar 

  35. Weiss SJ (1989) Tissue destruction by neutrophils. N Engl J Med 320: 365–376

    Article  PubMed  CAS  Google Scholar 

  36. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI (1991) Mucosal tumour necrosis factor a and interleukin-6 in patients with H. pylori associated gastritis. Gut 32: 1473–1477

    Article  PubMed  CAS  Google Scholar 

  37. Engstrand L, Scheynius A, Pahlson C, Grimelius L, Schwan A, Gustavsson S (1989) Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 57: 827–832

    PubMed  CAS  Google Scholar 

  38. Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD (1991) Soluble surface proteins from H. pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 87: 894–900

    Article  PubMed  CAS  Google Scholar 

  39. Steinbeck MJ, Roth JA (1989) Neutrophil activation by recombinant cytokines. Rev Infect Dis 11: 549–568

    Article  PubMed  CAS  Google Scholar 

  40. Papadimitriou CS, Iaachim-Velogianni EE, Tsianos EB, Moutsopoulos HM (1988) Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch (A) 413: 197–204

    Article  CAS  Google Scholar 

  41. Lambert JR, Borromeo M, Korman MG, Hansky J (1987) Role of Campylobacter pyloridis in non-ulcer dyspepsia. A randomized controlled trial. Gastroenterology 91: 1488

    Google Scholar 

  42. Rathbone BJ, Wyatt JI, Worsley BW, Shires SE, Trejdosiewicz LK, Heatley RV, Losowsky MS (1986) Systemic and local antibody responses to Campylobacter pyloridis in non-ulcer dyspepsia. Gut 27: M2 - 647

    Article  Google Scholar 

  43. Rathbone BJ, Heatley RV (1989) Immunology of C. pylori infection. In: Blaser MJ (ed.) Campylobacter pylori in gastritis and peptic ulcer disease. Igaku Shoin, New York pp 135–140

    Google Scholar 

  44. Hessey SJ, Spencer J, Wyatt JL et al. (1990) Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31: 134–138

    Article  PubMed  CAS  Google Scholar 

  45. Smoot DT, Mobley HLR, Gillian T et al. (1989) Pedestal formation of H. pylori with gastric epithelial cells in vitro may require actin polymerization. Gastroenterology 5: A127

    Google Scholar 

  46. Evans DJ, Evans DG, Smith KE, Graham DY (1989) Serum antibody responses to the N-acetylneuraminyllactose-binding hemagglutinin of Cambylobacter pylori. Infect Immun 57: 664–667

    PubMed  CAS  Google Scholar 

  47. Wyle FA, Tarnawski A, Wadington S (1990) Pathogenesis of H. pylori gastric disease: the role of adherence. Amer J Gastroent 85: 1243

    Google Scholar 

  48. Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS (1992) Pathologic changes of gastric mucosa colonized by H. pylori. Hum Pathol 23: 548–556

    Article  PubMed  CAS  Google Scholar 

  49. Kazi JL, Sinniah R, Zaman V, Ng ML, Jafarey NA, Alam SM, Zuberi SJ, Kazi AM (1990) Ultrastructural study of H. pylori-associated gastritis. J Pathol 161: 65–70

    Article  PubMed  CAS  Google Scholar 

  50. Hazell SL, Lee A, Brady L, Hennessy W (1986) Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptations to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 153: 658–663

    Article  PubMed  CAS  Google Scholar 

  51. Chen XG, Correa P, Offerhaus J et al. (1986) Ultrastructure of the gastric mucosa harboring Campylobacter like organisms. Am J Clin Pathol 86: 575–582

    PubMed  CAS  Google Scholar 

  52. Bode G, Malfertheiner P, Ditschneit H (1988) Pathogenetic implications of ultrastructural finding in C. pylori related gastroduodenal disease. Scand J Gastroenterol 23: 25–39

    Article  Google Scholar 

  53. Wyle FA, Tarnawski A, Schulman D, Dabros W (1990) Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J Clin Gastroent 12 (suppl 1): 92–98

    Article  Google Scholar 

  54. Dick JD (1990) Helicobacter (Campylobacter) priori priori: a new twist to an old disease. Annu Rev Microbiol 44: 249–269

    Article  PubMed  CAS  Google Scholar 

  55. Rauws EAJ, Tytgat GNJ (1989) Campylobacter pylori. WC den Ouden, Amsterdam

    Google Scholar 

  56. Blaser MJ (1990) Epidemiology and pathophysiology of Campylobacter pylori infections. Rev Infect Dis 12 (suppl 1): 4–4–59

    Article  Google Scholar 

  57. Smoot DT, Mobley HLT, Chippendale GR, Lewison JF, Resau JH (1990) Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 58: 1992–1994

    PubMed  CAS  Google Scholar 

  58. Johnson WM, Lior H (1986) Production of heat-labile cytotoxin by Campylobacter pyloridis. Adv Intern Med 34: B234

    Google Scholar 

  59. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR (1988) Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med Microbiol 26: 93–99

    Article  PubMed  CAS  Google Scholar 

  60. Leunk RD (1991) Production of a cytotoxin by H. pylori. Rev Infect Dis 13 (suppl 8): S686–689

    Article  PubMed  Google Scholar 

  61. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ (1991) Effect of urease on HeLa cell vacuolation induced by H. pylori cytotoxin. Infect Immun 59: 1264–1270

    PubMed  CAS  Google Scholar 

  62. Cover TL, Blaser MJ (1992) Purification and characterization of the vacuolating toxin from H. pylori. J Biol Chem 267: 10570–10575

    PubMed  CAS  Google Scholar 

  63. Cover TL, Dooley CP, Blaser MJ (1990) Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 58: 603–610

    PubMed  CAS  Google Scholar 

  64. Guerrant RI, Barrett LJ, Marshall BJ (1991) Cytotoxin production by Campylobacter pylori. In: Ruiz-Palacios G (ed.) Campylobacter V. Mexico City, Instituto Nacional de la Nutricion

    Google Scholar 

  65. Eaton KA, Morgan DR, Krakowka S. (1989) Campylobacter pylori virulence factors in gnotobiotic piglets. Infect Immun 57: 1119–1125

    PubMed  CAS  Google Scholar 

  66. Tricottet V, Bruneval P, Vire O, Camilleri JP, Bloch R, Bonte N, Roge J (1986) Campylobacter- like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: an ultrastructural study. Ultrastruct Pathol 10: 113–122

    Article  PubMed  CAS  Google Scholar 

  67. Leunk RD, Ferguson MA, Morgan DR, Low DE, Simor AE (1990) Antibody to cytotoxin in infection by H. pylori. J Clin Microbiol 28: 1181–1184

    PubMed  CAS  Google Scholar 

  68. Cover TL, Cao P, Blaser MJ (1991) Neutralization of H. pylori cytotoxin-induced HeLa cell vacuolation by human sera. Gastroenterology 100: A570

    Google Scholar 

  69. Chang K, Fujiwara Y, Wyle F, Tarnawski A (1992) H. pylori toxin inhibits growth and proliferation of cultured gastric cells — Kato III. J Phys Pharm (in press)

    Google Scholar 

  70. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S (1989) Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol 27: 225–226

    PubMed  CAS  Google Scholar 

  71. Slomiany BL, Kasinathan C and Slomiany A (1989) Lipolytic activity of Campylobacter pylori: effect of colloidal bismuth subcitrate (De-No 1). Amer J Gastroent 84: 1273–1277

    PubMed  CAS  Google Scholar 

  72. Langton SR, Cesaarco SD (1992) H. pylori associated phospholipase A2 activity: a factor in peptic ulcer production? J Clin Pathol 45: 221–224

    Article  PubMed  CAS  Google Scholar 

  73. Raedsch R, Stiehl A, Waldherr R, Pasch B, Kommereil B (1988) Elevated concentrations of not amidated and secondary bile acids and lysolecithin in gastric juice in the presence of Campylobacter pylori. Gastroenterology 94: A257

    Google Scholar 

  74. Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Benveniste J (1990) PAF-acether synthesis by H. pylori. Gut 31: 1242–1245

    Article  PubMed  CAS  Google Scholar 

  75. Rosam AC, Wallace JL, Whitde BJR (1990) Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 319: 54–56

    Article  Google Scholar 

  76. Wallace JL, Whittle BJR (1986) Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins 31: 989–998

    Article  PubMed  CAS  Google Scholar 

  77. Levi S, Beardshell K, Haddad G, Playford R, Ghosh P, Calam J (1989) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1: 1167–1168

    Article  PubMed  CAS  Google Scholar 

  78. Smith JTL, Pounder RE, Evans DJ, Graham DY, Evans DG (1989) Inappropriate 24 hour hypergastrinemia in asymptomatic C. pylori infection. Gut 30: A732 - A733

    Article  Google Scholar 

  79. Karnes WE, Ohning GV, Sytnik B, Kim SWR, Walsh JH (1991) Preservation of pH inhibition of gastrin release in subjects with H. pylori. Rev Infect Dis 13: S665 - S670

    Article  PubMed  Google Scholar 

  80. Graham DY, Opekun A, Lew GM, Evans Jr DJ, Klein PD, Evans DG (1990) Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of H. ( Campylobacter) pylori infection. Am J Gastoenterol 85: 394–398

    CAS  Google Scholar 

  81. Samloff IM (1989) Peptic ulcer: The many proteinases of aggression. Gastroenterology 96 (suppl): 586–595

    PubMed  CAS  Google Scholar 

  82. Veenendaal RA, Biemond I, Pena AS, van Duijn W, Kreuning J, Lames CBHW. (1992) Influence of age and H. pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 33: 452–455

    Article  PubMed  CAS  Google Scholar 

  83. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY (1992) Relationship of H. pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 102: 760–766

    PubMed  CAS  Google Scholar 

  84. Oderda G, Vaira D, Holton J, Dowsett JF, Ansaldi N (1989) Serum eosinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 30: 912–916

    Article  PubMed  CAS  Google Scholar 

  85. Samoff IM, Varis K, Ihamaki T, Siurala M, Rotter JI (1982) Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 83: 204–209

    Google Scholar 

  86. Westerveld BB, Pals G, Lamers CBHW, Defize J, Pronk JC, Frants RR (1987) Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 59: 952–958

    Article  PubMed  CAS  Google Scholar 

  87. Wyle FA, Chang KJ (1993) H. pylori: are they different from one another/? Eur J Gastroent Hep (in press)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wyle, F.A., Chang, K.J., Tarnawski, A. (1993). Helicobacter pylori: Pathogenic Mechanisms. In: Domschke, W., Konturek, S.J. (eds) The Stomach. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78176-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78176-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56613-7

  • Online ISBN: 978-3-642-78176-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation